Atovaquone/proguanil

Atovaquone/proguanil, sold under the brand name Malarone among others, is a fixed-dose combination medication used to treat and prevent malaria, including chloroquine-resistant malaria. It contains atovaquone and proguanil. It is not recommended for severe or complicated malaria. It is taken by mouth. Atovaquone/proguanil was approved for medical use in the United States in 2000. It has been available as a generic medication since 2011.

Atovaquone/proguanil

Atovaquone/proguanil, sold under the brand name Malarone among others, is a fixed-dose combination medication used to treat and prevent malaria, including chloroquine-resistant malaria. It contains atovaquone and proguanil. It is not recommended for severe or complicated malaria. It is taken by mouth. Atovaquone/proguanil was approved for medical use in the United States in 2000. It has been available as a generic medication since 2011.